Renal Flashcards
What are the key features of nephritic syndrome?
- Haematuria → visible or non-visible
- Oliguria
- Proteinuria → <3g
- Fluid & salt retention → hypertension
- Pyuria → sterile leukocytes
What is the most common cause of nephritic syndrome in adults?
IgA nephropathy - Berger’s Disease
How does IgA Nephropathy typically present?
Young patient (20s), macroscopic haematuria 24-48hrs after an upper respiratory tract infection.
Other features:
- Oliguria
- Proteinuria → <3g
- Fluid & salt retention → hypertension
- Pyuria → sterile leukocytes
What condition will have the following result on renal biopsy: IgA deposits in mesangial proliferation ?
IgA Nephropathy - Berger’s Disease.
How is IgA Nephropathy managed?
- High-dose prednisolone → reduce proteinuria & delay renal impairment
- Other immunosuppressive drugs can be used in patients with deteriorating renal function.
What is the typical presentation of Post-Streptococcal Glomerulonephritis?
2 weeks after infection with nephritic syndrome → haematuria, oliguria, oedema, hypertension
What investigation is key when diagnosing Post-Streptococcal Glomerulonephritis?
Raised anti-streptolysin O titre - this confirms recent strep infection
How is post-streptococcal glomerulonephritis managed?
- Supportive, careful monitoring of fluid balance
- Usually self-limiting, particularly in children
What is the diagnostic criteria for an AKI?
- Rise in creatinine of >25 in 48hrs
- Rise in creatinine of >50% from baseline in 7 days
- Urine output <0.5ml/kg/hour
What 2 drugs are given to slow progression of CKD?
- ACE inhibitors → need to monitor potassium & this plus CKD can cause hyperkalaemia
- SGLT2 inhibitors (dapagliflozin) → slow rate of progression, reduce incidence of CVD
What are the 3 key complications of CKD, and how are they managed?
- Anaemia:
- Due to decreased EPO production
- Iron first, then EPO-stimulating agents
- Renal bone disease:
- Decreased activated vitamin D (reduced calcium), PTH stimulating osteoclast activity
- Low phosphate diet (avoid fizzy drinks)
- Phosphate binders
- Active forms of vitamin D (cicitriol)
- Increased calcium intake
- Bisphosphonates if osteoporosis
- Metabolic acidosis → sodium bicarbonate
What is the medical management of benign prostatic hyperplasia?
- Alpha agonists → tamsulosin
- Relaxes smooth muscle of the urethra & prostate
- Causes a rapid improvement of symptoms
- Side effects → headaches, postural hypotension, ejaculation problems, nasal congestion
- 5-alpha reductase inhibitors → finasteride
- Essentially reduces the amount of dihydrotestosterone in the tissues, leading to a reduction in prostate size.
- Takes up to 6 months of treatment for the effects to result in improved symptoms
- Side effects → erectile dysfunction, loss of libido
What surgical management is considered for BPH?
- TURP → transurethral resection of the prostate
- Most common surgical treatment of BPH
- Side-effects → bleeding, infection, incontinence, ED, retrograde dysfunction
What investigations are done for suspected bladder cancer?
Cystoscopy → used to visualise bladder cancers.
CT CAP → if they are suspected to have muscle-invasive bladder cancer after cystoscopy
How is bladder cancer managed?
-
TURBT → for NMIBlCa
- Trans-Urethral Resection of Bladder Tumour
- Intravesical chemotherapy → often used after TURBT through a catheter to reduce the risk of recurrence.
-
Radical cystectomy → removal of the entire bladder
- There are several options for urine following this, most commonly being urostomy with an ileal conduit